UM - University of Montpellier
Université of Montpellier is a research-intensive university where education and research cover most of the Scientific and Technological fields. UM gathers around 41000 students and 4300 staffs with an overall budget of 380 million euros. The studies are organized in the following fields: Fundamental and applied Sciences, Human and Social Sciences (law, economy), Health studies. Research is structured within 72 laboratories in partnership with well-recognized research organizations such as CNRS, IRD, INRA or CIRAD. Moreover, in terms of innovation UM is linked to 8 Competitiveness Clusters in the Region Languedoc Roussillon. These clusters include enterprises, training centers, laboratories (public or private) with the goal to create new collaborations and projects for a better competitiveness at the international level. At the international level, UM is one of the most attractive universities in France in terms of student exchange (it represents more than 7500 incoming students for the last years), research collaboration (for example, the number of PhD in co-supervision with international universities is around 120 for the two merged institutions), as well as international projects (Research and Education).
The dynamism and the influence of its laboratories, coupled with a professionalizing policy, make the university contribute strongly to the socioeconomic development of the region, through the employability of its students. The university takes part in 6 competitiveness clusters that form a network of companies, research units and educational structures, offering collaborative and competitive solutions for joint projects. Very recently, Université de Montpellier (UM) received the “HR Excellence in Research” award from the European Commission (EC) for its Human Resources Strategy for Research (HRS4R). UM is the first French university to receive this distinction. The HR Excellence in Research award recognizes Université de Montpellier’s efforts concerning its Human Resources policy, including researcher recruitment, career management, specific needs of the research profession, support for national and international research projects, and PhD student supervision. "
(UMR 1183 ) IRMB :
Gathers scientist and medical expertise on regenerative medicine and innovative immunotherapies with the objectives to increase the knowledge of stem cell biology, reprogrammation and interactions between stem cells and immune cells, stem cell niches and homing, as well as the role of epigenetics mechanisms in chronic and age related diseases. These researches include both basic biological aspects and innovative applications of regenerative therapy. The aim of this unit is to facilitate the transfer of research on stem cell biology to clinical applications in consultation with clinical specialists in chronic diseases (rheumatoid arthritis, rare genetic diseases, autoinflammatory disorders, diabetes, liver disease, musculoskeletal disorders) with the support of national infrastructures in health biology dedicated to stem cells (ECELLFrance and INGESTEM).
ECELLFrance is the French Network Infrastructure for mesenchymal stem cell (MSC)-based therapies. Since its creation in 2012, it has been involved in over 20 national and European research & innovation programs in cell-based therapy.
It brings together :
• State-of-the-art Advanced Therapy Medicinal Products (ATMP) production platforms
• Immunomonitoring and quality control platforms
• Research teams with expertise on translational research in cell therapy
• Clinical research teams to cover phase I and II clinical studies
Pascale Plence, PhD
Group leader at the IRMB, member of the Team 3 “Genetics and Immunopathology of joint inflammatory disorders” leaded by Florence Apparailly.
In charge of the Immunomonitoring platform of the SITIM lab and Infrastructure EcellFrance
Engineer in charge of the cytometry core facilities.
ECELLFrance project manager.